Dr. Mai Tariq Mohamed Nassar is a Senior Quality Assurance Specialist at the Egyptian Drug Authority (EDA) and CAPA Responsible, bringing over 15 years of extensive experience in regulatory affairs and quality management.

Holding a master’s degree in quality management (MQM), with deep expertise in the development, implementation, and continuous improvement of Quality Management Systems (QMS), Dr. Mai Nassar specializes in the management of non-conformities and the effective execution of Corrective and Preventive Actions (CAPA) within EDA.

While playing a pivotal role in advancing the EDA KPI Framework, contributing to the development, monitoring, and evaluation of regulatory performance, Dr. Mai Nassar contributes to international capacity-building by supporting regulatory authorities in Yemen, South Africa (SAHPRA), and Kenya, with a focus on strengthening regulatory systems and promoting best practices.

In addition, Dr. Mai Nassar a key member of the strategic team that responsible for developing and continuously updating the EDA Strategic Plan, including refining the Authority’s vision, mission, and strategic objectives.

Dr. Nahed Yaish is a QMS and PV Consultant, QPPV Auditor, and Qualified International Trainer. With 23 years of experience in the pharmaceutical industry, she has spent 18 years serving as a Qualified Person Responsible for Pharmacovigilance (QPPV), Local Safety Responsible, and Quality Assurance Responsible Person. She is also a QPPV Auditor and a Qualified International Trainer certified by the International College in London.

Maya Chebbo is an Executive Quality Leader with over 20 years of international experience across pharmaceuticals, consumer health, medical devices, cosmetics, and FMCG.

Currently serving as Group Quality Head, she leads end-to-end quality strategy and compliance across manufacturing networks, commercial operations, and global supply chains within complex regulatory environments.

Holding a Master’s degree in Biochemistry and an Industrial Engineering degree specialized in Quality Management, Maya has led major quality transformations, governance model design, enterprise-wide QMS implementation, M&A due diligence, and post-merger integrations for international acquisitions, ensuring seamless regulatory compliance and operational excellence. She brings deep expertise in global regulatory inspections, including FDA, EU, ANVISA, SFDA, and Russian authorities, operating with a pragmatic, risk-based, audit-ready mindset.

Maya believes quality is not merely a compliance function, but a strategic enabler of sustainable growth and business performance. She is also a strong advocate for diversity, inclusion, and health and mental well-being, championing cultures of collaboration, accountability, and continuous improvement.

Mohamed Abdallah is a pharmaceutical industry leader with over 17 years of experience across the UAE, KSA, and Egypt. He has held senior roles within leading organizations including Julphar, Tabuk Pharmaceuticals, GlaxoSmithKline, and Sigma-Tec.

Currently he is Quality Director at Julphar, Mohamed leads end-to-end quality operations across a diversified pharmaceutical network supplying more than 40 countries in different continents. His scope spans sterile and non-sterile dosage forms as well as advanced drug substance manufacturing, ensuring compliance with global regulatory standards while supporting sustainable business growth.

Previously, as Site Head at Tabuk Pharmaceuticals in KSA, he led a specialty manufacturing site serving KSA, GCC, Jordan, and Africa where he successfully drove a tangible cost optimisation along with strengthened inspection readiness frameworks and supported new product launches and facility expansions.

During his tenure at GlaxoSmithKline (GSK) in Egypt, Mohamed served as Site Quality Head and member of the Site Leadership Team, successfully leading the site through multiple regulatory, corporate, and third-party audits, including pre-approval inspections. He played a pivotal leadership role during the COVID-19 crisis and complex corporate transition periods, maintaining regulatory trust while ensuring uninterrupted patient supply. Prior to this he led Analytical Lab and held different positions in the Production areas.

Dr. Mona Al Moussli is the Co-Founder and Managing Director of PRA Consultancy, with over 20 years of expertise in pharmaceutical and medical device regulatory affairs. She has led key initiatives like the GCC Regulatory Affairs Summit and the AfriSummit and developed the GCC Regulatory Affairs Course. Dr. Al Moussli also serves on several advisory boards, contributing to healthcare advancement and regulatory excellence in the region.

Mona El‑Hawary is the Head of Quality at Haleon responsible for Saudi Arabia, Gulf & Near East . With over 15 years in quality operations, Mona specializes in GMP/GDP compliance, regulatory affairs, and product lifecycle management across Middle East and Africa. She is known for strengthening QMS maturity, leading and maintaining audit readiness programs, driving data integrity improvement plans and operational excellence across complex networks.